Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome

L Andreoli, M Fredi, C Nalli, R Reggia, A Lojacono… - Journal of …, 2012 - Elsevier
Multidisciplinary approach and patient counselling have been the key points in the improvement
of the management of pregnancy in women with systemic lupus erythematosus (SLE) …

A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus

…, F Dall'Ara, M Fredi, C Nalli, R Reggia… - Journal of …, 2016 - Elsevier
Nowadays, most of the young women affected by Systemic Lupus Erythematosus (SLE) can
carry out one or more pregnancies thanks to the improvement in treatment and the …

Pregnancy in patients with autoimmune disease: a reality in 2016

A Tincani, F Dall'Ara, MG Lazzaroni, R Reggia… - Autoimmunity …, 2016 - Elsevier
Autoimmune rheumatic diseases are chronic systemic conditions often affecting young women
during their reproductive years, so that pregnancy is a major issue in their management. …

Effects of belimumab on flare rate and expected damage progression in patients with active systemic lupus erythematosus

L Iaccarino, S Bettio, R Reggia, M Zen… - Arthritis Care & …, 2017 - Wiley Online Library
Objective To investigate effectiveness and safety of belimumab in patients with active systemic
lupus erythematosus (SLE) in a clinical practice setting. Methods Sixty‐seven patients …

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric …

…, PL Meroni, M Mosca, G Pazzola, R Reggia… - Journal of …, 2018 - Elsevier
Objective To investigate efficacy, safety and survival of belimumab and to identify predictors
of drug response and drug discontinuation in patients with active SLE in clinical practice. …

Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study

M Taraborelli, R Reggia, F Dall'Ara, M Fredi… - The Journal of …, 2017 - jrheum.org
Objective. To assess the longterm frequency of thrombotic recurrences, obstetrical complications,
organ damage, severe comorbidities, and evolution toward connective tissue disease (…

Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies

…, M Fredi, C Nalli, S Piantoni, R Reggia… - Current rheumatology …, 2013 - Springer
IgA antiphospholipid antibodies (aPL) are not currently recognized as formal laboratory
criteria for the Antiphospholipid Syndrome (APS). This is mainly due to methodological issues (…

“Disease knowledge index” and perspectives on reproductive issues: a nationwide study on 398 women with autoimmune rheumatic diseases

…, MG Lazzaroni, C Carini, F Dall'Ara, C Nalli, R Reggia… - Joint Bone Spine, 2019 - Elsevier
Objective The reproductive choices of women affected by rheumatic diseases (RD) can be
influenced by several factors, including the quality of physician-patient communication. We …

Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?

R Reggia, T Ziglioli, L Andreoli, F Bellisai… - …, 2012 - academic.oup.com
… Sir, we read with interest the multicentre and retrospective report by Reggia, et al. (1)
about the role of serum complement levels in Primary APS (PAPS) in predicting pregnancy …

Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes

F Crisafulli, L Andreoli, D Zucchi, R Reggia… - The Journal of …, 2023 - jrheum.org
Objective To analyze complement level variations in systemic lupus erythematosus (SLE)
pregnancies, focusing on disease flares and obstetric complications. Methods SLE …